391 related articles for article (PubMed ID: 16411206)
1. Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors.
Hunold A; Weddeling N; Paulussen M; Ranft A; Liebscher C; Jürgens H
Pediatr Blood Cancer; 2006 Nov; 47(6):795-800. PubMed ID: 16411206
[TBL] [Abstract][Full Text] [Related]
2. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group.
Bernstein ML; Devidas M; Lafreniere D; Souid AK; Meyers PA; Gebhardt M; Stine K; Nicholas R; Perlman EJ; Dubowy R; Wainer IW; Dickman PS; Link MP; Goorin A; Grier HE; ; ;
J Clin Oncol; 2006 Jan; 24(1):152-9. PubMed ID: 16382125
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide and topotecan as first-line salvage therapy in patients with relapsed ewing sarcoma at a single institution.
Farhat R; Raad R; Khoury NJ; Feghaly J; Eid T; Muwakkit S; Abboud M; El-Solh H; Saab R
J Pediatr Hematol Oncol; 2013 Jul; 35(5):356-60. PubMed ID: 23042020
[TBL] [Abstract][Full Text] [Related]
4. Serial intense chemotherapy combining topotecan, etoposide, carboplatin and cyclophosphamide (TECC) followed by autologous hematopoietic stem cell support in patients with high risk soft tissue sarcoma (STS).
Bernbeck B; Bahci S; Meisel R; Troeger A; Schönberger S; Laws HJ; Kramm C; Wessalowski R; Koscielniak E; Dilloo D; Göbel U
Klin Padiatr; 2007; 219(6):318-22. PubMed ID: 18050041
[TBL] [Abstract][Full Text] [Related]
5. Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
Al-Faris N; Al Harbi T; Goia C; Pappo A; Doyle J; Gassas A
Pediatr Blood Cancer; 2007 Aug; 49(2):190-5. PubMed ID: 17262797
[TBL] [Abstract][Full Text] [Related]
6. A modified protocol with vincristine, topotecan, and cyclophosphamide for recurrent/progressive ewing sarcoma family tumors.
Kebudi R; Cakir FB; Gorgun O; Agaoglu FY; Darendeliler E
Pediatr Hematol Oncol; 2013 Apr; 30(3):170-7. PubMed ID: 23484903
[TBL] [Abstract][Full Text] [Related]
7. [High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS].
Fröhlich B; Ahrens S; Burdach S; Klingebiel T; Ladenstein R; Paulussen M; Zoubek A; Jürgens H
Klin Padiatr; 1999; 211(4):284-90. PubMed ID: 10472563
[TBL] [Abstract][Full Text] [Related]
8. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.
Oberlin O; Rey A; Desfachelles AS; Philip T; Plantaz D; Schmitt C; Plouvier E; Lejars O; Rubie H; Terrier P; Michon J;
J Clin Oncol; 2006 Aug; 24(24):3997-4002. PubMed ID: 16921053
[TBL] [Abstract][Full Text] [Related]
9. Carboplatin-based chemotherapy for refractory and recurrent Ewing's tumours.
Whelan JS; McTiernan A; Kakouri E; Kilby A;
Pediatr Blood Cancer; 2004 Sep; 43(3):237-42. PubMed ID: 15266407
[TBL] [Abstract][Full Text] [Related]
10. Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital experience, 1979-1999.
Rodriguez-Galindo C; Billups CA; Kun LE; Rao BN; Pratt CB; Merchant TE; Santana VM; Pappo AS
Cancer; 2002 Jan; 94(2):561-9. PubMed ID: 11900241
[TBL] [Abstract][Full Text] [Related]
11. Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol.
Kellie SJ; Boyce H; Dunkel IJ; Diez B; Rosenblum M; Brualdi L; Finlay JL
J Clin Oncol; 2004 Mar; 22(5):846-53. PubMed ID: 14990640
[TBL] [Abstract][Full Text] [Related]
12. Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults.
Kolb EA; Kushner BH; Gorlick R; Laverdiere C; Healey JH; LaQuaglia MP; Huvos AG; Qin J; Vu HT; Wexler L; Wolden S; Meyers PA
J Clin Oncol; 2003 Sep; 21(18):3423-30. PubMed ID: 12972518
[TBL] [Abstract][Full Text] [Related]
13. Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma.
Shankar AG; Ashley S; Craft AW; Pinkerton CR
Med Pediatr Oncol; 2003 Mar; 40(3):141-7. PubMed ID: 12518341
[TBL] [Abstract][Full Text] [Related]
14. Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999.
Bacci G; Longhi A; Ferrari S; Mercuri M; Barbieri E; Bertoni F; Bacchini P; Picci P
Eur J Surg Oncol; 2006 Nov; 32(9):974-9. PubMed ID: 16621429
[TBL] [Abstract][Full Text] [Related]
15. High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer.
Donato ML; Gershenson DM; Wharton JT; Ippoliti CM; Aleman AS; Bodurka-Bevers D; Bevers MW; Burke TW; Levenback CF; Wolf JK; Freedman RS; Bast RC; Gajewski JL; Champlin RE
Gynecol Oncol; 2001 Sep; 82(3):420-6. PubMed ID: 11520135
[TBL] [Abstract][Full Text] [Related]
16. Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group study.
Hawkins DS; Bradfield S; Whitlock JA; Krailo M; Franklin J; Blaney SM; Adamson PC; Reaman G
Pediatr Blood Cancer; 2006 Nov; 47(6):790-4. PubMed ID: 16435380
[TBL] [Abstract][Full Text] [Related]
17. Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment.
Argon A; Basaran M; Yaman F; Dizdar Y; Sakar B; Camlica H; Bavbek SE; Ozger H; Darendeliler E; Onat H
Jpn J Clin Oncol; 2004 Nov; 34(11):667-72. PubMed ID: 15613556
[TBL] [Abstract][Full Text] [Related]
18. Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group.
Miser JS; Goldsby RE; Chen Z; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore SG; Rausen AR; Vietti TJ; Grier HE
Pediatr Blood Cancer; 2007 Dec; 49(7):894-900. PubMed ID: 17584910
[TBL] [Abstract][Full Text] [Related]
19. Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults.
Kushner BH; Cheung NK; Kramer K; Dunkel IJ; Calleja E; Boulad F
Bone Marrow Transplant; 2001 Sep; 28(6):551-6. PubMed ID: 11607767
[TBL] [Abstract][Full Text] [Related]
20. Survival after recurrence of Ewing's sarcoma family of tumors.
Barker LM; Pendergrass TW; Sanders JE; Hawkins DS
J Clin Oncol; 2005 Jul; 23(19):4354-62. PubMed ID: 15781881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
